Paid Clinical Trials Colorado Springs
Discover 298 paid clinical trials in Colorado Springs, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Dato-DXd & PembrolizumabDatopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
Sponsor:
Daiichi Sankyo
Location:
Code:
NCT05555732
Conditions
Metastatic Non Small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Datopotamab Deruxtecan
Pembrolizumab
Pemetrexed
Carboplatin
Cisplatin
ElafibranorA Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Sponsor:
Ipsen
Location:
Code:
NCT06016842
Conditions
Primary Biliary Cholangitis (PBC)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Elafibranor
Matched 80 mg placebo
KHK4951Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration
Sponsor:
Kyowa Kirin Co., Ltd.
Location:
Code:
NCT06116890
Conditions
Neovascular Age-Related Macular Degeneration (nAMD)
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Interventions
KHK4951
Aflibercept Injection
FF/UMEC/VI vs. FF/VIA Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Sponsor:
GlaxoSmithKline
Location:
Code:
NCT05757102
Conditions
Asthma
Eligibility Criteria
Sex: All
Age: 12 - 17
Healthy Volunteers: Not accepted
Interventions
FF/UMEC/VI
ELLIPTA
FF/VI
DeucrictibantStudy of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema
Sponsor:
Pharvaris Netherlands B.V.
Location:
Code:
NCT06343779
Conditions
Hereditary Angioedema
Hereditary Angioedema Type I
Hereditary Angioedema Type II
Hereditary Angioedema Types I and II
Hereditary Angioedema Attack
Eligibility Criteria
Sex: All
Age: 12 - 70+
Healthy Volunteers: Not accepted
Interventions
Deucrictibant, Placebo
Interested in new trials?
Get alerts for new trials in your area by subscribing now
BarzolvolimabA Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Sponsor:
Celldex Therapeutics
Location:
Code:
NCT06455202
Conditions
Chronic Spontaneous Urticaria
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
barzolvolimab
Matching placebo
Genio® Bilateral StimulationSafety and Effectiveness of the Genio® bilAteral Stimulation for Treatment of Complete Concentric CollapsE and OSA.
Sponsor:
Nyxoah S.A.
Location:
Code:
NCT05592002
Conditions
Sleep Apnea, Obstructive
Eligibility Criteria
Sex: All
Age: 22 - 70+
Healthy Volunteers: Not accepted
Interventions
Genio System
TezepelumabOpen-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
Sponsor:
AstraZeneca
Location:
Code:
NCT06473779
Conditions
Severe Asthma
Eligibility Criteria
Sex: All
Age: 12 - 70+
Healthy Volunteers: Not accepted
Interventions
Tezepelumab
Budesonide/formoterol
Albuterol/budesonide (AIRSUPRA®)
Mannitol
Salbutamol
Targeted TherapiesStudy of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Sponsor:
AbbVie
Location:
Code:
NCT06548542
Conditions
Crohn's Disease
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Risankizumab
Lutikizumab
ABBV-382